[1] |
Li Jianqin, Sheng Yueyue, Zhou Yinmin, Shi Weiqing, Yang Xingchen.
Safety of clopidogrel combined with statins on acute coronary syndrome in patients based on metabolic pathways by different cytochrome P450 enzyme: a Meta analysis
[J]. Clinical Focus, 2022, 37(2): 101-105.
|
[2] |
Cui Guoyan, Zheng Wen, Zhang Liwei.
Clinical efficacy of lidocaine combined with rosuvastatin in treating acute coronary syndrome concurrent with acute arrhythmia among patients intolerant of amiodarone
[J]. Clinical Focus, 2021, 36(4): 311-314.
|
[3] |
Liu Yuanliang, Li Biao, Jiang Zuofeng, Zhu Youfeng, Zhang Shaoheng, Wang Yarong, Li Rongseng, Li Li.
Efficacy and safety of half-dose versus standard-dose of tirofiban for percutaneous coronary intervention in elderly Chinese patients with acute coronary syndrome: a meta-analysis
[J]. Clinical Focus, 2021, 36(11): 965-971.
|
[4] |
Qiu Siyue1, Yang Haiyu2, Yu Tao2, Huang Zhichao1, Zhang Zixin1.
Impact of estimated glomerular filtration rate on nosocomial prognosis in patients with acute coronary syndrome
[J]. Clinical Focus, 2020, 35(6): 498-502.
|
[5] |
Zhang Han, Shi Yunke, Zhang Min, Cai Hongyan, Li Jian, .
The influence of family stress on the quality of life and physical recovery of male and female patients with acute coronary syndrome
[J]. Clinical Focus, 2020, 35(12): 1078-1083.
|
[6] |
He Zhengfei, Wang Diqing, He Xiaolan, Sun Linggang.
Related factors of slow coronary flowno reflow after percutaneous coronary angioplasty for acute coronary syndrome
[J]. Clinical Focus, 2020, 35(11): 971-975.
|
[7] |
Rao Mingyue, Wang Yaling, Zhang Guoru, Wang Mei.
Advances in anticoagulant therapy after acute coronary syndrome
[J]. Clinical Focus, 2018, 33(9): 761-766.
|
[8] |
Li Liang Wang Mei.
Research progress on antiplatelet therapy in special populations of acute coronary syndrome
[J]. Clinical Focus, 2018, 33(9): 767-770.
|
[9] |
Pan Guangjie,Chen Huili,Gu Yunfei,Liu Lei,Chen Yan,Li Songsen,Ma Huifang,Jin Jun,Zhang Shouyan.
Current situation and related factors of coronary intervention treatment in patients with non STelevation acute coronary syndrome
[J]. Clinical Focus, 2017, 32(7): 591-594.
|
[10] |
Xia Jinggang, Xu Ji, Hao Hengjian, Yin Chunlin, Xu Dong.
Relationship between apolipoprotein E gene polymorphism and shortterm prognosis in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(7): 579-582.
|
[11] |
Teng Xin1, Qin Qin2, Lu Yaru2, Yang Ning2.
Relation between platelet parameters and clinical classification and severity of acute coronary syndrome
[J]. Clinical Focus, 2017, 32(6): 487-490.
|
[12] |
Liu Xiaoyu,Jia Guowei,Sun Rongguo,Ma Bocong,Zhao Ming,Zhang Hongbin,Zhang Wei.
Ticagrelor and clopidogrel on PCI perioperative hsCRP in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(5): 421-424.
|
[13] |
Wang Yanbo,Gu Xinshun,Hao Guozhen,Jiang Yunfa,Fan Weize,Fu Xianghua.
Incidence and risk factors of type 1 cardiorenal syndrome in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(4): 310-313.
|
[14] |
Hu Zhiling1, Li Fang2, Li Xiang2, Wang Xiaowei3, Yang Shuang2.
Predictive value of two methods of platelet function detection for VerifyNow and Multiplate in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(12): 1049-1052.
|
[15] |
Li Yanhong, Guo Honghui, Li Xiaojiang, Pan Haiqin, Yao Shuyan, Ma Lan, Li Yun, Hao Yujie.
Association of COFNLR with clinicopathological characteristics and prognosis of patients with nonsmallcell lung cancer after curative resection
[J]. Clinical Focus, 2016, 31(7): 762-766.
|